Granules India Share Price
₹592.40 -7.65 (-1.27%)
21 Dec, 2024 18:14
Start SIP in GRANULES
Start SIPPerformance
- Low
- ₹590
- High
- ₹613
- 52 Week Low
- ₹365
- 52 Week High
- ₹721
- Open Price₹603
- Previous Close₹600
- Volume3,942,427
Investment Returns
- Over 1 Month + 7.19%
- Over 3 Month + 9.72%
- Over 6 Month + 25.43%
- Over 1 Year + 57.47%
Smart Investing Starts Here Start SIP with Granules India for Steady Growth!
Granules India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 29.5
- PEG Ratio
- 1.2
- Market Cap Cr
- 14,365
- P/B Ratio
- 4.5
- Average True Range
- 21.2
- EPS
- 20.09
- Dividend Yield
- 0.3
- MACD Signal
- 4.87
- RSI
- 55.59
- MFI
- 50.15
Granules India Financials
Granules India Technicals
EMA & SMA
- Bullish Moving Average 13
- Bearish Moving Average 3
- 20 Day
- ₹581.24
- 50 Day
- ₹577.19
- 100 Day
- ₹568.91
- 200 Day
- ₹531.96
Resistance and Support
- R3 629.10
- R2 620.80
- R1 606.60
- S1 584.10
- S2 575.80
- S3 561.60
Granules India Corporate Actions - Bonus, Splits, Dividends
Granules India F&O
About Granules India
Granules India Ltd. is vertically integrated pharmaceutical company based in India, specializing in manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), & finished dosages. Established in 1984, company has strong presence in global pharmaceutical market, supplying its products to over 300 customers in more than 60 countries. Granules India's focus on cost-efficient manufacturing, quality assurance, & regulatory compliance has enabled it to become trusted partner for leading pharmaceutical companies worldwide. company's commitment to innovation & expansion has driven its growth in highly competitive pharmaceutical industry.
With six tons of batch processing capacity, it is one of biggest PFI makers in India. Since its PFIs are made to transfer straight from drums to hoppers, it has established itself as top supplier to major international pharmaceutical corporations.
The strategy focus on high-value formulations & drop in API sales are to blame for change in revenue contribution.
Beyond top five heritage items, company is expanding its product line; as of FY24, new products account for 25% of total sales, up from 19% in FY22.
- NSE Symbol
- GRANULES
- BSE Symbol
- 532482
- Chairman & Managing Director
- Dr. Krishna Prasad Chigurupati
- ISIN
- INE101D01020
Similar Stocks to Granules India
Granules India FAQs
Granules India share price is ₹592 As on 21 December, 2024 | 18:00
The Market Cap of Granules India is ₹14365.3 Cr As on 21 December, 2024 | 18:00
The P/E ratio of Granules India is 29.5 As on 21 December, 2024 | 18:00
The PB ratio of Granules India is 4.5 As on 21 December, 2024 | 18:00
Consider company's market position in pharmaceutical industry & its growth prospects before investing.
Key metrics include revenue from key products, profit margins, & regulatory approvals.
Open Demat account with 5 Paisa Capital & post doing KYC & active account search for Granules India share, you can then put order as you prefer.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.